Inactive Instrument
Sector Cell Therapeutics Inc Nasdaq
Stocks
US1509346029
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 27/06/23 | DRI Healthcare Trust Receives US$54.8 Million in Debt Repayment | MT |
| 27/06/23 | DRI Healthcare Trust Announces USD 54.8 Million Debt Repayment from CTI Biopharma Corp | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.78% | -1.68% | -3.40% | +19.86% | +4.61% | +1.99% | +13.84% | -22.53% | +197.67% | 49.24B | |
| -0.48% | -1.74% | +8.98% | +34.86% | +153.08% | +459.63% | +571.93% | +687.11% | - | 43.3B | |
| -2.57% | -0.37% | +13.19% | +13.91% | +14.21% | +12.04% | +69.98% | +23.67% | +1,099.38% | 40.48B | |
| -0.89% | +0.24% | +15.13% | +40.19% | +6.15% | +26.34% | +8.70% | -6.27% | +212.74% | 39.75B | |
| -0.50% | +3.08% | +14.79% | +10.79% | +16.60% | +19.91% | +47.26% | -11.26% | +153.13% | 32.67B | |
| +0.29% | -3.16% | -6.86% | +0.76% | - | - | - | - | - | 16.23B | |
| -0.66% | -2.26% | +7.68% | +37.74% | +2.80% | +25.88% | +117.36% | +212.50% | +1,875.87% | 16.24B | |
| +0.49% | +0.92% | +2.09% | +18.59% | +12.88% | +4.32% | +22.16% | -39.00% | +86.20% | 14.04B | |
| -0.90% | +4.06% | +20.38% | +74.92% | +39.53% | +78.65% | +28.33% | -33.10% | +234.18% | 13.43B | |
| -2.14% | -0.23% | -2.29% | +40.17% | -9.93% | -6.40% | -36.68% | -31.73% | +113.49% | 12.92B | |
| -1.37% | +24.04% | +44.13% | +79.86% | +72.78% | +59.27% | +66.51% | -46.61% | - | 12.3B | |
| -0.06% | -0.21% | +1.28% | +61.24% | +22.67% | +34.24% | -14.94% | -39.56% | +158.89% | 11.25B | |
| -3.66% | -9.99% | -13.48% | -0.77% | -14.70% | +74.07% | +498.48% | +291.24% | +2,339.43% | 10.6B | |
| -1.41% | -0.52% | +9.53% | +3.87% | +21.77% | +652.41% | +2,017.41% | +81.95% | - | 10.29B | |
| +0.05% | -0.24% | +0.41% | +60.30% | +78.21% | +252.86% | +496.50% | - | - | 10.14B | |
| -2.77% | +1.21% | -10.21% | +15.83% | -10.79% | -26.41% | - | - | - | 9.8B | |
| +0.95% | +4.66% | +16.30% | +44.64% | +74.80% | +177.63% | +701.42% | +219.06% | +1,227.57% | 9.8B | |
| +0.95% | +7.32% | +2.95% | +36.56% | +48.30% | +177.71% | +477.24% | +126.70% | - | 9.51B | |
| +0.30% | -0.85% | +2.09% | -25.90% | -29.11% | +30.88% | +40.62% | +45.17% | +58.19% | 9.28B | |
| Average | -0.85% | +2.93% | +6.46% | +29.86% | +27.99% | +114.17% | +301.54% | +91.08% | +646.40% | 19.54B | |
| Weighted average by Cap. | -1.04% | +2.82% | +7.41% | +28.08% | +32.88% | +107.80% | +219.57% | +112.55% | +551.17% |
- Stock Market
- Stocks
- CTIC Stock
- Stock
- Sector Cell Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
